Patent · US Active

Method of treating cancer

US11116759B2 · kind B2 · utility

0Cited by
16References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 26, 2018
Grant dateSep 14, 2021
Priority date—
Expiry dateSep 26, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention is directed to the treatment of cancer, particularly ocular melanoma, with a dual inhibitor of MET and VEGF such as Compound 1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.